בוסטריקס פוליו ישראל - עברית - Ministry of Health

בוסטריקס פוליו

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.

קימריה ישראל - עברית - Ministry of Health

קימריה

novartis israel ltd - tisagenlecleucel - tisagenlecleucel

סונטה 12.5 ישראל - עברית - Ministry of Health

סונטה 12.5

unipharm trading ltd, israel - sunitinib as malate - קפסולה קשיחה - sunitinib as malate 12.5 mg - sunitinib

סונטה 25 ישראל - עברית - Ministry of Health

סונטה 25

unipharm trading ltd, israel - sunitinib as malate - קפסולה קשיחה - sunitinib as malate 25 mg - sunitinib

סונטה 37.5 ישראל - עברית - Ministry of Health

סונטה 37.5

unipharm trading ltd, israel - sunitinib as malate - קפסולה קשיחה - sunitinib as malate 37.5 mg - sunitinib

סונטה 50 ישראל - עברית - Ministry of Health

סונטה 50

unipharm trading ltd, israel - sunitinib as malate - קפסולה קשיחה - sunitinib as malate 50 mg - sunitinib

בוסטריקס ישראל - עברית - Ministry of Health

בוסטריקס

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); pertactin (prn or 69 kda omp); pertussis toxoid (pt); tetanus toxoid - תרחיף להזרקה - diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid (pt) 8 mcg / 0.5 ml; pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml - tetanus toxoid, combinations with diphtheria toxoid - tetanus toxoid, combinations with diphtheria toxoid - for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of ten years onwards.